Home / Inspections / 1085599

FDA Inspection 1085599 — The Center for Reproductive Endocrinology

The Center for Reproductive Endocrinology — FEI 3003927090

The FDA completed an inspection of The Center for Reproductive Endocrinology on April 2, 2019 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 2, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Dallas, TX (United States)

Facility

Other inspections at this facility

  • 1261706 (NAI Wed Feb 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 968356 (NAI Wed Apr 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 858696 (VAI Fri Dec 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 677301 (NAI Thu Aug 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources